Back to Companies
AN2 Therapeutics, Inc.
ANTXNasdaqCIK: 0001880438
Over the 50 most recent insider filings, AN2 Therapeutics, Inc. (ANTX) has seen activity from 15 distinct insiders — 1 buying and 6 selling. The activity is heavily weighted toward selling: $11.6K bought versus $398.3K sold, net sales of $386.7K. Easom Eric is the most active by dollar volume, and the single largest transaction was $8.7M by Easom Eric. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$22.5M
Purchases
$11.6K
Sales
$398.3K
Unique Insiders
15
Recent Insider Trades
50 loaded
| Sep 16 | ANTX AN2 Therapeutics, Inc. | Trenor Cameron C. III | Insider | Grant | $1.3M |
| Sep 11 | ANTX AN2 Therapeutics, Inc. | Readnour Robin Shane | Insider | Sell | $6.7K |
| Sep 8 | ANTX AN2 Therapeutics, Inc. | Readnour Robin Shane | Insider | Sell | $97.3K |
| Sep 2 | ANTX AN2 Therapeutics, Inc. | FitzPatrick Margaret M | Insider | Buy | $11.6K |
| Sep 4 | ANTX AN2 Therapeutics, Inc. | Williams Sarah Joanne | Insider | Sell | $1.5K |
| Aug 27 | ANTX AN2 Therapeutics, Inc. | Trenor Cameron C. III | Insider | Other | $0 |
| Aug 19 | ANTX AN2 Therapeutics, Inc. | Readnour Robin Shane | Insider | Sell | $212.7K |
| Aug 14 | ANTX AN2 Therapeutics, Inc. | Zakrzewski Joseph S | Insider | Gift | $0 |
| Jul 10 | ANTX AN2 Therapeutics, Inc. | Marks Gilbert Lynn | Insider | Grant | $0 |
| Jul 10 | ANTX AN2 Therapeutics, Inc. | Martin Patricia A. | Insider | Grant | $0 |
| Jul 10 | ANTX AN2 Therapeutics, Inc. | Aziz Kabeer | Insider | Grant | $0 |
| Jul 10 | ANTX AN2 Therapeutics, Inc. | Eizen Joshua M | Insider | Sell | $24.8K |
| Jun 2 | ANTX AN2 Therapeutics, Inc. | Williams Sarah Joanne | Insider | Sell | $1.2K |
| Apr 10 | ANTX AN2 Therapeutics, Inc. | Aziz Kabeer | Insider | Grant | $0 |
| Apr 10 | ANTX AN2 Therapeutics, Inc. | Martin Patricia A. | Insider | Grant | $0 |
| Apr 10 | ANTX AN2 Therapeutics, Inc. | Marks Gilbert Lynn | Insider | Grant | $0 |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | Day Lucy | Insider | Award | $2.8M |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | Zakrzewski Joseph S | Insider | Award | $979.0K |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | Marks Gilbert Lynn | Insider | Award | $389.7K |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | Aziz Kabeer | Insider | Award | $498.4K |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | FitzPatrick Margaret M | Insider | Award | $528.5K |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | Readnour Robin Shane | Insider | Award | $498.4K |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | Wong Stephanie | Insider | Award | $484.3K |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | Chanda Sanjay | Insider | Award | $2.2M |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | Eizen Joshua M | Insider | Award | $2.4M |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | Spigelman Melvin K | Insider | Award | $477.1K |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | Easom Eric | Insider | Award | $8.7M |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | Martin Patricia A. | Insider | Award | $484.3K |
| Mar 5 | ANTX AN2 Therapeutics, Inc. | Williams Sarah Joanne | Insider | Sell | $347 |
| Feb 23 | ANTX AN2 Therapeutics, Inc. | Wong Stephanie | Insider | Award | $21.2K |
| Feb 23 | ANTX AN2 Therapeutics, Inc. | Aziz Kabeer | Insider | Award | $21.2K |
| Feb 23 | ANTX AN2 Therapeutics, Inc. | FitzPatrick Margaret M | Insider | Award | $21.2K |
| Feb 23 | ANTX AN2 Therapeutics, Inc. | Readnour Robin Shane | Insider | Award | $21.2K |
| Feb 23 | ANTX AN2 Therapeutics, Inc. | Williams Sarah Joanne | Insider | Grant | $0 |
| Feb 23 | ANTX AN2 Therapeutics, Inc. | Day Lucy | Insider | Grant | $80.1K |
| Feb 23 | ANTX AN2 Therapeutics, Inc. | Zakrzewski Joseph S | Insider | Award | $21.2K |
| Feb 23 | ANTX AN2 Therapeutics, Inc. | Spigelman Melvin K | Insider | Award | $21.2K |
| Feb 23 | ANTX AN2 Therapeutics, Inc. | Eizen Joshua M | Insider | Grant | $104.0K |
| Feb 23 | ANTX AN2 Therapeutics, Inc. | Chanda Sanjay | Insider | Grant | $80.1K |
| Feb 3 | ANTX AN2 Therapeutics, Inc. | Williams Sarah Joanne | Insider | Other | $0 |
| Jan 14 | ANTX AN2 Therapeutics, Inc. | Aziz Kabeer | Insider | Grant | $0 |
| Jan 14 | ANTX AN2 Therapeutics, Inc. | Martin Patricia A. | Insider | Grant | $0 |
| Jan 14 | ANTX AN2 Therapeutics, Inc. | Marks Gilbert Lynn | Insider | Grant | $0 |
| Jan 7 | ANTX AN2 Therapeutics, Inc. | Chanda Sanjay | Insider | Sell | $9.3K |
| Jan 7 | ANTX AN2 Therapeutics, Inc. | Prior Stephen David | Insider | Sell | $6.5K |
| Jan 7 | ANTX AN2 Therapeutics, Inc. | Eizen Joshua M | Insider | Sell | $25.0K |
| Jan 7 | ANTX AN2 Therapeutics, Inc. | Day Lucy | Insider | Sell | $8.9K |
| Nov 6 | ANTX AN2 Therapeutics, Inc. | Eizen Joshua M | Insider | Sell | $3.2K |
| Nov 6 | ANTX AN2 Therapeutics, Inc. | Prior Stephen David | Insider | Sell | $872 |
| Oct 14 | ANTX AN2 Therapeutics, Inc. | Martin Patricia A. | Insider | Grant | $0 |
50 filings+